Company Legal Name
Latest Valuation
Founded Year
Headquarter
Tahoe Therapeutics is a biotechnology company that leverages artificial intelligence models combined with in vivo data to accelerate drug discovery and development. Founded in 2022 and headquartered in South San Francisco, the company differentiates itself by integrating AI-driven computational approaches with real-world biological data to identify therapeutic candidates that can benefit broader patient populations. This hybrid methodology aims to address traditional drug discovery limitations by improving target identification and reducing development timelines. As an early-stage company, Tahoe Therapeutics is focused on building its AI platform capabilities and advancing its pipeline of drug candidates across multiple therapeutic areas.
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
How can I buy Tahoe Therapeutics pre-IPO shares through Jarsy?
You can create an account, complete KYC verification, and start investing from just $10. Shares are fractionalized, so you can access pre-IPO opportunities without high entry barriers.
What is the current stock price and valuation of Tahoe Therapeutics ?
The latest valuation of Tahoe Therapeutics is , The live stock price chart shows historical price movements and company valuation trends. Investors can track performance before the IPO.
What is the minimum investment amount required to invest in Tahoe Therapeutics ?
The minimum investment is $10, enabling fractionalized access to Tahoe Therapeutics pre-IPO shares.
What fees will I pay when investing in Tahoe Therapeutics pre-IPO shares?
Fees include platform fees and carried interest on realized profits.
What risks are involved in Tahoe Therapeutics pre-IPO stock investments?
Risks include liquidity lock-ups, valuation uncertainty, industry-specific risks, regulatory changes, and potential custody or tokenization issues.
How does Jarsy ensure transparency of reserves and assets?
Each Jarsy issued Token is backed 1:1 by the economic rights of a corresponding share held by Jarsy’s Delaware LLC ( an LLC created for custody purposes). When a liquidation event happens, Jarsy would liquidate the shares and return the equivalent dollar value to token holders based on their economic interest. This structure ensures full transparency and direct backing of every token. All the supply and transactions information of the token can be verified independently through blockchain.
Can I sell my Tahoe Therapeutics pre-IPO shares backed token before the IPO?
You may redeem your tokens through the Jarsy platform; however, settlement is not guaranteed and is subject to available liquidity and market demand.